AU3991499A - Independent regulation of basal and insulin-stimulated glucose transport - Google Patents

Independent regulation of basal and insulin-stimulated glucose transport

Info

Publication number
AU3991499A
AU3991499A AU39914/99A AU3991499A AU3991499A AU 3991499 A AU3991499 A AU 3991499A AU 39914/99 A AU39914/99 A AU 39914/99A AU 3991499 A AU3991499 A AU 3991499A AU 3991499 A AU3991499 A AU 3991499A
Authority
AU
Australia
Prior art keywords
basal
insulin
glucose transport
independent regulation
stimulated glucose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39914/99A
Inventor
Francesco Giorgino
Robert J. Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Joslin Diabetes Center Inc
Original Assignee
Joslin Diabetes Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Joslin Diabetes Center Inc filed Critical Joslin Diabetes Center Inc
Publication of AU3991499A publication Critical patent/AU3991499A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93Ligases (6)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/53Ligases (6)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
AU39914/99A 1998-05-15 1999-05-14 Independent regulation of basal and insulin-stimulated glucose transport Abandoned AU3991499A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8569598P 1998-05-15 1998-05-15
US60085695 1998-05-15
PCT/US1999/010666 WO1999059559A1 (en) 1998-05-15 1999-05-14 Independent regulation of basal and insulin-stimulated glucose transport

Publications (1)

Publication Number Publication Date
AU3991499A true AU3991499A (en) 1999-12-06

Family

ID=22193347

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39914/99A Abandoned AU3991499A (en) 1998-05-15 1999-05-14 Independent regulation of basal and insulin-stimulated glucose transport

Country Status (2)

Country Link
AU (1) AU3991499A (en)
WO (1) WO1999059559A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5840300A (en) * 1999-07-14 2001-01-30 University Of Lausanne Glutx polypeptide family and nucleic acids encoding same
DE10305212A1 (en) * 2003-02-07 2004-08-19 Florian Prof. Dr.med. Lang Use of the sgk gene family for the diagnosis and therapy of cataracts and glaucoma
US9777044B2 (en) 2003-05-02 2017-10-03 Centre National De La Recherche Scientifique (Cnrs) GLUT-1 as a receptor for HTLV envelopes and its uses
WO2004096841A1 (en) 2003-05-02 2004-11-11 Centre National De La Recherche Scientifique Glut-1 as a receptor for htlv envelopes and its uses
DK2376917T3 (en) 2009-01-09 2016-07-18 Centre Nat Rech Scient New receptorbindingsligander, use thereof for the detection of cells of biological interest

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639458A (en) * 1987-03-20 1997-06-17 Regents Of The University Of California Class I MHC modulation of surface receptor activity

Also Published As

Publication number Publication date
WO1999059559A1 (en) 1999-11-25

Similar Documents

Publication Publication Date Title
AU3536699A (en) 3-arylphenyl sulfide derivatives and insecticides and miticides
AU5802499A (en) Diet composition and method of weight management
AU2485100A (en) Left and right side heart support
IL141471A0 (en) Regulation of substrate activity
AU3052899A (en) Determination of apnea type
AU5587499A (en) Antisense modulation of g-alpha-16 expression
AU5239399A (en) Antisense modulation of g-alpha-13 expression
AU3790399A (en) Blood set and chamber
AU1732395A (en) Certain cerulenin-geranyl and dodecanoic acid derivatives
AU4325199A (en) Antisense modulation of g-alpha-11 expression
AU7948298A (en) Microstrip structure
AU4650199A (en) Conveyer, conveyer drive, and usage of conveyer
AU2500600A (en) Antisense modulation of integrin beta 3 expression
AU758325C (en) Imidazole compounds and medicinal use thereof
AU2647295A (en) Personal carrier for partially consumed confections
AU6861498A (en) Conveyor arrangements with multiple shaftless screws
AU6157899A (en) Catheter flush solution and method for its use
AU6124999A (en) Hydrazinooxoacetamide derivatives and insecticide
AU8029798A (en) Insulin analogue
AU4442799A (en) Antisense modulation of elk-1 expression
AU1099701A (en) Alpha1-3 galactosyltransferase gene and promoter
AU9001598A (en) Thiourea derivatives
AU3991499A (en) Independent regulation of basal and insulin-stimulated glucose transport
AU5791799A (en) Xanthine compound preparations and new uses thereof
AU8275898A (en) Mesomorphic sugar and products therefrom

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase